Joseph Boswell, President of ACCESS Forum and Founder/President of GenMAV Inc., has been in the healthcare industry for over 25 years.  Rising upthrough pharmaceutical/biotech/medical device world, he worked through progressively higher levels at Wyeth-Ayerst, Johnson and Johnson (where he spent 14 years), and  12 years heading Business Development for Avalere Health in Washington DC before founding his own firm in 2020.  He has developed expertise in a wide array of therapeutic areas (including cardiovascular, diabetes, women’s health, depression, and obesity) as well as broader healthcare trends—especially as they relate to value, evidence and stakeholder engagement in the evolving healthcare marketplace.  He sits on the Boards of LiquidBiosciences and Embic corporations.
Joseph holds a BA in History from the University of California, Los Angeles and a Certificate in Strategic Alliances from Wharton at the University of Pennsylvania. He is a Certified Instructional Designer.

Dr. Diana Brixner is Emeritus Professor in the Department of
Pharmacotherapy and is a Founder of the Pharmacotherapy
Outcomes Research Center (PORC) at the University of Utah
in Salt Lake City, UT. She has been a member of both the
Huntsman Cancer Institute Cancer Control and Population
Sciences and the Center for Genomic Medicine. She also
serves as a principal of the Millcreek Outcomes Group, LLC where she consults on
translating evidence to value to support payer decision making. Prior to her
academic appointment in 2002 she worked both in the biotech (NeoRx) and
pharmaceutical (SmithKline Beecham, Novartis) industry focused on value
assessment of their technologies in the early years of the field. Dr. Brixner was a Past President of both the Academy of Managed Care Pharmacy (AMCP) and
International Society of Pharmacoeconomics and Outcomes Research (ISPOR). She
has served as a one-year Scholar-in-Residence for the Academy of Managed Care
Pharmacy, recently served on the scientific advisory board of Lumanity and is a
member of the Executive Board of the International Market Access Society.
Education & Training:
Dr. Brixner received her B.S. degree in 1982 from the University of Rhode Island,
Pharmacy. In 1987 she received her Ph.D. in Medicinal Chemistry from the
University of Utah. She received a Modeling Approaches for Health Technology
Assessment Certificate in 2010, a Clinical Epidemiology Certificate in 2013 and a
Certificate in the Introduction to Health Technology Assessment in 2015 from the
University of Health Sciences, Medical Informatics and Technology, Hall in Tirol,
Austria where she did a sabbatical in 2011.
Research Interests:
Dr. Brixner's research focus is on the design, conduct, and communication of
pharmacoeconomic and outcomes research studies to demonstrate the value of
pharmaceutical and related therapies from the perspective of the private and public payer. Much of her work is focused on oncology and personalized medicine. She has published over 150 articles in peer-reviewed journals, authored three book chapters, has one issued patent, and has been an invited speaker at a variety of national and international professional meetings.
Publications: Diana Brixner Publication list PubMed
Email: diana.brixner@utah.edu

Dr. Shadi Saleh is Founding Director of the Global Health Institute (GHI) at the American University of Beirut (AUB), the first such institute in the Middle East and North Africa region. In addition, he is a Professor of Health Systems and Financing. Previously, he served as an Associate Vice President for Health Affairs and as the Chairman of the Department of Health Management at Policy at AUB; and as a Professor of Health Systems at the State University of New York.
Dr. Saleh’s areas of expertise are in evidence-based decision-making in health care, health system strengthening and financing and health economics and outcomes research (HEOR), with a focus on the pharmaceutical sector.  He has published over 150 peer-reviewed papers and commissioned reports, including publications in the Lancet, American Journal of Public Health and Medical Care among others.
Dr. Saleh served as an elected board member of the Consortium of Universities in Global Health; He is also a Head of Delegation with the M8 Alliance and an Executive Board Member of the International Market Access Society. Dr. Saleh served as an appointed member of the National Emergency Social Protection Project and the Committee on Universal Health Coverage with the Ministry of Public Health in Lebanon. Dr. Saleh also serves as a World Bank, WHO and UN advisor for health care financing policy and system strengthening projects. In 2022, he was awarded the Velji Award for Global Health Leadership.
Shadi Saleh holds a PhD in Health Policy (minor in health care finance) from the University of Iowa and a Masters of Public Health (health services administration) and a BS from AUB.